iFyber receives U.S. Army research Ffunding for wound healing technology

NewsGuard 100/100 Score

The United States Army Medical Research and Material Command, through the support of the Department of Defense Small Business Innovation Research Grant Program (SBIR), has awarded iFyber a Phase I grant.  The award funds research related to controlled release of nitric oxide for wound healing. 

Aaron Strickland, PhD, Vice President of Research and Development and co-founder of iFyber, is the principal investigator on this effort and will guide the collaborative work with industry and university partners. The SBIR project involves a collaboration between iFyber and Professor C.C. Chu, an internationally recognized biomaterials researcher at the College of Human Ecology at Cornell University, as well as other researchers at the University of Buffalo. 

The process of wound healing, particularly in diabetics and immunologically compromised patients, can be both difficult and protracted. The financial cost along with the loss of productivity associated with impaired healing processes could be significantly curtailed if innovative, cost-effective technologies could be developed.

“iFyber is leveraging its knowledge of surface chemistry and materials science by initiating collaborations in scientific fields which alone may be limited, but together can be very powerful in industry,” said Dr. Strickland.   Eric Eisenhut, President of iFyber, further noted, “Receiving this award through the competitive SBIR process has provided us with resources to further validate our technology as it relates to our focus on functional coatings for wound care materials.”

iFyber, LLC is a materials science company advancing coating technologies used to functionalize natural and synthetic fibers in the industrial, medical, military and consumer markets.  iFyber’s technology enables the deposition of conformal, nanoparticle coatings on both flat and curved surfaces using a unique layer-by-layer assembly process. The process provides for the ability to control particle size and inter-particle spacing which in turn allows iFyber to impart a remarkable array of custom properties to treated fibrous materials.  Custom properties include electrical conductivity, self-cleaning, anti-microbial action, and authentication technology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer